Your browser doesn't support javascript.
loading
Pramipexole attenuates 6-OHDA-induced Parkinson's disease by mediating the Nurr1/NF-κB pathway.
Gao, Hua; Wang, Dan; Wang, Yu-Ling; Mao, Jie-Ping; Jiang, Sen; Yang, Xin-Ling.
Afiliação
  • Gao H; Department of Neurology, Second Hospital Affiliated of Xinjiang Medical University, No. 38, South Lake Road, Ürümqi, 830063, Xinjiang, China.
  • Wang D; Department of Neurology, Fifth Affiliated Hospital of Xinjiang Medical University, Ürümqi, 830011, Xinjiang, China.
  • Wang YL; Department of Neurology, Second Hospital Affiliated of Xinjiang Medical University, No. 38, South Lake Road, Ürümqi, 830063, Xinjiang, China.
  • Mao JP; Cadre Health Center, First Affiliated Hospital of Xinjiang Medical University, Ürümqi, 830054, Xinjiang, China.
  • Jiang S; Department of Neurology, Urumqi Friendship Hospital, Ürümqi, 830049, Xinjiang, China.
  • Yang XL; Department of Neurology, Second Hospital Affiliated of Xinjiang Medical University, No. 38, South Lake Road, Ürümqi, 830063, Xinjiang, China.
Mol Biol Rep ; 48(4): 3079-3087, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33891271

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / NF-kappa B / Membro 2 do Grupo A da Subfamília 4 de Receptores Nucleares / Pramipexol Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / NF-kappa B / Membro 2 do Grupo A da Subfamília 4 de Receptores Nucleares / Pramipexol Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article